Medsfirst Ltd

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—4

Registered number: 10735217

		2025		2024
	Notes	£	£	£	£
FIXED ASSETS
Tangible Assets	4		613,162		305,084

			613,162		305,084
CURRENT ASSETS
Debtors	5	-		11,793
Investments	6	2,013,845		2,013,845
Cash at bank and in hand		11,294		44,753

		2,025,139		2,070,391
Creditors: Amounts Falling Due Within One Year	7	(1,513,993 )		(1,387,527 )

NET CURRENT ASSETS (LIABILITIES)			511,146		682,864

TOTAL ASSETS LESS CURRENT LIABILITIES			1,124,308		987,948

Creditors: Amounts Falling Due After More Than One Year	8		(671,257 )		(712,912 )

NET ASSETS			453,051		275,036

CAPITAL AND RESERVES
Called up share capital	9		100		100
Profit and Loss Account			452,951		274,936

SHAREHOLDERS' FUNDS			453,051		275,036

Page 1

Page 2

Medsfirst Ltd

Balance Sheet (continued)

As At 31 October 2025

For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Anish Harish Dholakia Director	Raxa Anish Dholakia Director
22/06/2026

The notes on pages 3 to 4 form part of these financial statements.

1. General Information

Medsfirst Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 10735217 . The registered office is Suite F16, St. Georges Business Park, Castle Road, Sittingbourne, Kent, ME10 3TB.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Freehold

3. Average Number of Employees

Average number of employees, including directors, during the year was:

	2025	2024
Directors	2	2

	2	2

4. Tangible Assets

	Land & Property
	Freehold
	£
Cost
As at 1 November 2024	305,084
Additions	308,078

As at 31 October 2025	613,162

Net Book Value
As at 31 October 2025	613,162

As at 1 November 2024	305,084

5. Debtors

	2025	2024
	£	£
Due within one year
Prepayments and accrued income	-	293
Other debtors	-	11,500

	-	11,793

Page 3

Page 4

Medsfirst Ltd

Notes to the Financial Statements (continued)

For The Year Ended 31 October 2025

6. Current Asset Investments

	2025	2024
	£	£
Unlisted investments	2,013,845	2,013,845

7. Creditors: Amounts Falling Due Within One Year

	2025	2024
	£	£
Trade creditors	1,270	-
Bank loans and overdrafts	103,864	110,406
Accruals and deferred income	42,000	-
Directors' loan accounts	424,882	547,022
Amounts owed to group undertakings	941,977	730,099

	1,513,993	1,387,527

8. Creditors: Amounts Falling Due After More Than One Year

	2025	2024
	£	£
Bank loans	671,257	712,912

9. Share Capital

	2025	2024
	£	£
Allotted, Called up and fully paid	100	100